News

Killam Apartment REIT Outlines Q3 2024 Financial Results and Call

Killam Apartment REIT Outlines Q3 2024 Financial Results and Call

Killam Apartment REIT Announces Q3 2024 Financial Results

Killam Apartment REIT (TSX: KMP) is preparing to share its financial results for the third quarter of 2024. The results will be disclosed after the Toronto Stock Exchange closes on a Wednesday in early November. Attaching key importance to transparency and communication, the company invites investors and stakeholders to participate in an upcoming conference call.

Details of the Webcast and Conference Call

A live conference call is scheduled for Thursday, allowing participants to discuss the quarterly results and get insight into Killam's ongoing business initiatives. This interactive session will start promptly at 9:00 AM ET. Interested parties are encouraged to dial in using the designated numbers for North America or overseas. For those located in North America, a toll-free option is available at 1-888-699-1199, while participants outside North America can reach the call at 1-416-945-7677.

Accessing the Live Webcast

The live webcast will be easily accessible on Killam's official website. Listeners can find the link conveniently in the company's investor relations section. This initiative not only reflects Killam's commitment to keeping stakeholders informed but also enhances engagement with the company.

Replay of the Webcast

For those unable to attend live, a replay of the webcast will remain available for a full year after the event. This ensures that all interested parties have the opportunity to catch up on the discussion, making the financial information more widely accessible.

About Killam Apartment REIT

Killam Apartment REIT operates with a vision to enhance value across its extensive real estate portfolio, currently valued at approximately $5.3 billion. Focused on residential properties, the company is recognized as one of Canada’s leading real estate investment trusts, actively managing and developing various apartment and manufactured home communities.

Strategic Growth Initiatives

The company's strategic plan revolves around three key priorities: 1) boosting earnings from existing operations through efficiency and innovation, 2) growing its portfolio via accretive acquisitions and the thoughtful disposal of properties focused on newer developments, and 3) delivering well-constructed properties in core markets that align with Killam's growth strategy. This deliberate focus positions the company for sustainable growth in a competitive sector.

Investor Relations Contact

For further information, investors are welcome to reach out to Claire Hawksworth, Senior Manager of Investor Relations at Killam. Claire brings expertise and a commitment to a transparent dialogue with stakeholders. She can be contacted directly via email or at her office number. It’s vital for the company to maintain open lines of communication and address any inquiries efficiently.

Frequently Asked Questions

What is the date for the Q3 results announcement?

The Q3 results for Killam Apartment REIT will be announced after the close of the Toronto Stock Exchange on a Wednesday in early November 2024.

How can I watch the live webcast?

The live webcast will be accessible through Killam's investor relations section on their official website on the day of the call.

Is there a way to catch the webcast later?

Yes, a replay of the webcast will be available for one year after the event, allowing stakeholders to catch up on any missed information.

Who can I contact for more information?

For more information, you may contact Claire Hawksworth, Senior Manager, Investor Relations, at Killam.

What markets does Killam focus on?

Killam Apartment REIT primarily focuses on residential markets and is dedicated to expanding into areas that support their growth strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 33

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 32

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 25

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 32

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

TKO Group Launches Major Share Buyback and Dividend Initiative

Updated Category News Views 669

TKO Group Announces Strategic Financial Moves TKO Group Holdings, Inc. (NYSE: TKO) has recently made headlines with its announcement of a remarkable share repurchase program amounting to $2 billion. Alongside this significant initiative, the company is introducing a quarterly cash dividend that is projected to reach $75 million. These strategic financial maneuvers reflect...

Continue Reading
An Insightful Look at Warner Bros. Discovery's Declining Short Interest

Updated Category News Views 64

Understanding Warner Bros. Discovery's Short Interest Trends Warner Bros. Discovery (WBD) has seen a noteworthy drop in its short percent of float, falling by 11.22% since the last report. Currently, the company reports that there are 101.75 million shares sold short, representing about 4.67% of all available shares for trading. Interestingly, based on the current trading...

Continue Reading
Avobis Bio Advances Clinical Trials for Innovative Therapy Solutions

Updated Category News Views 185

Avobis Bio Unveils Breakthrough in Clinical Trial for AVB-114 Avobis Bio LLC, a pioneering company focused on developing innovative implantable cell therapies, has made a remarkable stride by completing the primary analysis of the STOMP-II randomized clinical trial targeting Crohn's perianal fistulas. This analysis brings with it exciting prospects for FDA interaction and...

Continue Reading
Innovative Bait Accessory Enhances Fishing Experience

Updated Category News Views 239

Revolutionizing Fishing with a New Bait Accessory Fishing is more than just a hobby; it's a passion for many outdoor enthusiasts. That's why the recent invention of the E Z BAIT accessory is creating waves in the angling community. Designed for all fishing lovers, it aims to keep your bait right where you need it without missing a beat. Convenience at Your Fingertips...

Continue Reading
Oncoinvent ASA: Advancing Cancer Therapies with Financial Focus

Updated Category News Views 158

Oncoinvent ASA's Periodic Performance Highlights Oncoinvent is making strides in the oncology sector, particularly with its Phase 2 trial for ovarian cancer. This clinical-stage biotechnology company is diligently focusing on expanding its research scope while ensuring sound financial management practices. Their primary product, Radspherin®, is a radiopharmaceutical...

Continue Reading